Cancer and Tumor Profiling Market Size, Share, Trends, By Biomarker Type, By Cancer type, By Technology, By Process Type, By Application, and By Region Forecast to 2028

9127.87
Present Value (M$)
2021
18130
Forecast Value (M$)
2028
10.3%
CAGR (%)

The global cancer/tumor profiling market size is expected to reach USD 18.13 Billion in 2028 and register a revenue CAGR of 10.3% during the forecast period.

Main companies

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Siemens AG.
  • F-Hoffmann La Roche Ltd.
  • Nanostring Technologies Inc.
  • BioGenex
  • Neogenomics Laboratories Inc.
  • HTG Molecular Diagnostics Inc.
  • Perkin Elmer Inc.
  • CellCarta Inc.
  • Ribomed Biotechnologies Inc.
  • Perthera
  • Qiagen N.V.
  • Genscript Biotech Corporation
  • Caris Life Sciences
  • Personalis Inc.